Wellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization Mandate

Rhea-AI Summary

Wellgistics Health (NASDAQ:WGRX) selected Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda (R3) to begin building its patented PharmacyChain™ smart contracts pharmaceutical tracking system to support serialization mandates such as the DSCSA.

The company plans closed-loop HIPAA-compliant development and expects initial operation within its own pharmacy by the end of Q2 2026, with intent to roll out to 6,500+ independent pharmacies later in 2026. Wellgistics cites exclusive IP licensed from Datavault AI and highlights large addressable markets, including a $634 billion U.S. prescription drug market projected to $883 billion by 2030.

Positive

• Five blockchain platforms selected for PharmacyChain development
• Exclusive IP license from Datavault AI for smart contracts
• Targeting initial operation by end of Q2 2026
• Planned access to 6,500+ independent pharmacies in network

Negative

• Initial deployment limited to own pharmacy before broader rollout
• No signed commercial agreements with manufacturers or wholesalers disclosed
• Building on multiple platforms may increase integration complexity

News Market Reaction – WGRX

-9.18%

9 alerts

-9.18% News Effect

-18.7% Trough in 7 hr 54 min

-$2M Valuation Impact

$19M Market Cap

1.2x Rel. Volume

On the day this news was published, WGRX declined 9.18%, reflecting a notable negative market reaction. Argus tracked a trough of -18.7% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $2M from the company's valuation, bringing the market cap to $19M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

U.S. prescription drugs market 2024: $634 billion U.S. prescription drugs market 2030: $883 billion Blockchain in healthcare 2024: $11 billion +5 more

8 metrics

U.S. prescription drugs market 2024 $634 billion Current U.S. prescription drugs market size per Grandview Research

U.S. prescription drugs market 2030 $883 billion Projected U.S. prescription drugs market size by 2030 per Grandview Research

Blockchain in healthcare 2024 $11 billion Current global blockchain in healthcare market per Grandview Research

Blockchain in healthcare 2030 $214 billion Projected global blockchain in healthcare market by 2030 per Grandview Research

U.S. healthcare market $4.9 trillion Size of U.S. healthcare market referenced for smart contracts opportunity

Shiftable healthcare spending $1 trillion PwC-estimated opportunity to shift healthcare spending to digital-first care

Healthcare as a service 2024 $25 billion Current global healthcare as a service market per Grandview Research

Healthcare as a service 2030 $74 billion Projected healthcare as a service market by 2030 per Grandview Research

Market Reality Check

Price: $0.1930 Vol: Volume 754,913 is below t...

low vol

$0.1930 Last Close

Volume Volume 754,913 is below the 20-day average of 1,425,931, suggesting a subdued pre-news trading backdrop. low

Technical Shares at 0.2125 are trading below the 0.85 200-day MA and sit 96.98% below the 52-week high, hovering just 2.61% above the 52-week low.

Peers on Argus

Peers showed mixed moves, with PETS up 0.37%, HKPD up 1.5%, SCNX up 0.5%, HITI d...

Peers showed mixed moves, with PETS up 0.37%, HKPD up 1.5%, SCNX up 0.5%, HITI down 1.59%, and SSY up 9.31%. No peers appeared in the momentum scanner, pointing to stock-specific dynamics rather than a coordinated sector move.

Historical Context

5 past events · Latest: 2026-02-23 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
2026-02-23	Blockchain partnership	Positive	+9.8%	Expanded Datavault AI blockchain smart contracts partnership for HaaS integration.
2026-02-18	Strategic investment	Positive	+0.3%	Investment in mental health AI startup to extend EinsteinRx and PharmacyChain reach.
2026-02-11	Telehealth expansion	Positive	+4.0%	Expanded Tollo Health partnership adding telehealth and mental health AI services.
2026-02-09	NFL Alumni deal	Positive	-1.6%	NFL Alumni Health partnership to deploy EinsteinRx and PharmacyChain to new populations.
2026-01-12	IP partnership	Positive	+10.5%	Datavault AI licensing to add quantum key encryption to PharmacyChain platform.

Pattern Detected

Recent news around AI, partnerships, and PharmacyChain has often coincided with positive price reactions, though one partnership announcement saw a modest decline.

Recent Company History

Over the last few months, Wellgistics has focused on expanding its AI-enabled PharmacyChain™ platform and partnerships. Key steps included licensing intellectual property from Datavault AI, adding quantum key encryption, and broadening collaborations with Tollo Health and NFL Alumni Health. Several of these announcements produced positive moves of up to 10.54%, indicating the market has previously responded constructively to blockchain and AI integration milestones tied to PharmacyChain and EinsteinRx™.

Market Pulse Summary

The stock moved -9.2% in the session following this news. A negative reaction despite strategic prog...

Analysis

The stock moved -9.2% in the session following this news. A negative reaction despite strategic progress would fit a pattern where capital structure and listing risks weigh on sentiment. The stock has traded 96.98% below its 52-week high, while recent 8-Ks detailed convertible notes, liability settlements, and bid-price noncompliance. Even with prior moves up to 10.54% on AI and blockchain news, concerns around dilution, debt, and execution could temper enthusiasm.

Key Terms

smart contracts, blockchain, hipaa-compliant, drug supply chain security act (dscsa), +1 more

5 terms

smart contracts technical

"patent protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System"

Self-executing digital agreements whose terms are written as code and stored on a distributed ledger so they run automatically when preset conditions are met — like a vending machine that releases a snack only after you insert the right coins. Investors care because smart contracts can speed up transactions, cut middlemen, reduce errors and fraud, and create new ways to issue, trade or enforce financial assets, which affects costs, risk and regulatory oversight.

blockchain technical

"blockchain platforms to build PharmacyChain™ U.S. prescription drugs market project"

A blockchain is a digital record-keeping system that securely stores information across many computers, making it difficult to alter or tamper with. Think of it like a shared, unchangeable ledger that everyone can see and verify, ensuring transparency and trust. For investors, this technology offers a way to securely track transactions and assets without relying on a central authority, potentially reducing costs and increasing security.

hipaa-compliant regulatory

"establish closed-loop, HIPAA-compliant data transfers required to complete smart contracts"

HIPAA-compliant means that a product, service, or organization follows the U.S. Health Insurance Portability and Accountability Act’s rules for protecting patients’ private health information, including technical controls, physical safeguards, and record-keeping. For investors, compliance matters because it reduces risks of costly fines, lawsuits and reputational damage, and it can be a requirement to sell into healthcare markets — like having a certified lockbox and an audit trail that reassures customers and regulators.

drug supply chain security act (dscsa) regulatory

"serialization mandates, such as the United States' Drug Supply Chain Security Act (DSCSA"

A U.S. law that requires electronic tracking, verification and secure handling of prescription drugs as they move from manufacturers to pharmacies, aiming to prevent counterfeit, theft and contamination—think of it as giving every medicine a digital passport and a logged chain of custody. Investors should care because complying requires system upgrades and ongoing costs for manufacturers, distributors and pharmacies, which can reduce margins but also lower the risk of costly recalls, fraud and regulatory penalties.

tokenization technical

"building the 'Health Data Railroad' through tokenization and smart contracts."

Tokenization is the process of converting real-world assets or rights into digital tokens stored on a computer network. This allows assets, such as property or investments, to be divided into smaller parts, making them easier to buy, sell, or transfer electronically. For investors, tokenization can increase access to a wider range of investments and make transactions faster and more efficient.

AI-generated analysis. Not financial advice.

• Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain^™

• U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to Grandview Research^[1]

• Global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, according to Grandview Research^[2]

TAMPA, FLORIDA / ACCESS Newswire / March 5, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx^™ into its patented blockchain-enabled smart contracts platform PharmacyChain^™, today announced that it has completed its evaluation process to select the most suitable blockchain platforms on which to build smart contracts-enabled pharmaceutical drug tracking system PharmacyChain that will further enable industry-wide serialization mandates, such as the United States' Drug Supply Chain Security Act (DSCSA^[3]). The Company selected Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda (R3) as the most suitable blockchain platforms currently in use in order to initiate PharmacyChain development. The Company is seeking to complete the development work needed to establish closed-loop, HIPAA-compliant data transfers required to complete smart contracts within its own Wellgistics Pharmacy by the end of the second quarter of 2026.

"Now that we have identified what we believe are the best technologies currently available upon which to build PharmacyChain, we are beginning the development work needed to make it operational initially within our own pharmacy by the end of next quarter," said Prashant Patel, RPh, President & Interim-CEO of Wellgistics Health. "While we intend for PharmacyChain to be made available for our own pharmacy and the 6,500+ independent pharmacies within the Wellgistics Pharmacy Network later this year, we also believe that other major pharmacy industry participants may increasingly adopt similar solutions given our strong intellectual property position. We intend to build multiple PharmacyChain options on different blockchain platforms such that large manufacturers, wholesalers and pharmacies will be incentivized to work with us in order to gain access to our patented technology to help them improve their pharmaceutical supply chain management systems, delivering on our promise of building the 'Health Data Railroad' through tokenization and smart contracts. We intend to program PharmacyChain in such a way that other key aspects of the healthcare ecosystem will be able to seamlessly integrate their data in order to produce a best-in-class product for all key healthcare stakeholders."

Wellgistics' intellectual property, exclusively licensed from Datavault AI, creates a competitive advantage related to the use of smart contracts in the $4.9 trillion US healthcare market^[4]. PwC estimates $1 trillion opportunity to shift healthcare spending^[5] towards a digital-first, proactive, and personalized system of care that minimizes administrative burden. The global blockchain in healthcare market currently stands at $11 billion, and is projected to grow to $214 billion by 2030 according to Grandview Research, with compound annual rates expected to exceed 60% per year. The U.S. prescription drug market, where independent pharmacies play a vital role, represents a $634 billion market opportunity, projected to grow to $883 billion by 2030 according to Grandview Research. The global healthcare as a service market is expected to grow from $25 billion in 2024 to $74 billion by 2030 according to Grandview Research^[6] amid increasing adoption of cloud-based solutions across hospitals, clinics and insurance companies. Blockchain-based, tokenized smart contracts technology integration leveraging artificial intelligence will help significantly improve transparency in healthcare, delivering trust and efficiency while improving patient outcomes.

About Wellgistics Health, Inc.

Wellgistics Health (NASDAQ:WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx^™ into its patented blockchain-enabled smart contracts platform PharmacyChain^™ to optimize the prescription drug dispensing journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the development, implementation, and potential adoption of the Company's PharmacyChain^™ platform, anticipated benefits of blockchain and artificial intelligence technologies in healthcare, expected development timelines, and potential market opportunities. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Such risks and uncertainties include, among others, risks related to technology development and implementation, commercial adoption of the Company's solutions, regulatory developments, protection of intellectual property, and general market conditions, as well as other risks described in the Company's filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date of this press release, and the Company undertakes no obligation to update them except as required by law.

Wellgistics Media & Investor Contact

Media:
media@wellgisticshealth.com

Investor Relations:
IR@wellgisticshealth.com

^[1]https://www.grandviewresearch.com/industry-analysis/us-pharmaceuticals-market-report

^[2]https://www.grandviewresearch.com/industry-analysis/blockchain-technology-healthcare-market

^[3]https://www.fda.gov/drugs/drug-supply-chain-integrity/drug-supply-chain-security-act-dscsa

^[4]https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet#:~:text=Historical%20NHE%2C%202023:,the%207.8%25%20growth%20in%202022

^[5]https://www.pwc.com/us/en/industries/health-industries/library/future-of-health.html

^[6]https://www.grandviewresearch.com/industry-analysis/healthcare-software-as-a-service-market-report

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

FAQ

What blockchain platforms did Wellgistics (WGRX) select for PharmacyChain?

Wellgistics selected Hyperledger Fabric, Ethereum/Polygon, VeChain, Quorum/Besu and Corda (R3) as development platforms. According to the company, these five were identified as most suitable to build PharmacyChain for smart contracts-enabled pharmaceutical tracking and serialization compliance.

When will Wellgistics (WGRX) have PharmacyChain operational internally?

The company expects initial internal operation by the end of Q2 2026. According to the company, development aims to complete closed-loop, HIPAA-compliant smart contract transfers within its own pharmacy by that deadline.

How many pharmacies could access PharmacyChain through Wellgistics (WGRX)?

Wellgistics intends to make PharmacyChain available to its 6,500+ independent pharmacies later in 2026. According to the company, the rollout plan targets the Wellgistics Pharmacy Network following the initial internal deployment.

Does Wellgistics (WGRX) have intellectual property for PharmacyChain?

Yes. Wellgistics uses intellectual property exclusively licensed from Datavault AI for its smart contracts platform. According to the company, the exclusive license creates a competitive advantage for PharmacyChain in healthcare supply chains.

What market opportunity does PharmacyChain target for Wellgistics (WGRX)?

PharmacyChain targets the U.S. prescription drug market and broader healthcare blockchain opportunity. According to the company, the U.S. prescription drug market is $634 billion and projected to $883 billion by 2030.

How will PharmacyChain help meet DSCSA serialization requirements for WGRX?

PharmacyChain is designed to enable smart contracts-enabled drug tracking to support DSCSA mandates. According to the company, the platform will provide closed-loop, HIPAA-compliant data transfers to improve serialization and supply chain transparency.